Valuation: Evogene Ltd.

Market Cap 5.73M 0 5.01M 4.63M 4.25M 8.04M 552M 8.18M 55.22M 21.69M 270M 21.51M 21.04M 931M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 5.73M 0 5.01M 4.63M 4.25M 8.04M 552M 8.18M 55.22M 21.69M 270M 21.51M 21.04M 931M EV / Sales 2026 *
3.86x
EV / Sales 2027 * 2.2x
Free-Float
82.9%
Yield 2026 *
-
Yield 2027 * -
1 day+3.85%
1 week+19.87%
Current month+35.19%
1 month+6.42%
3 months-29.48%
6 months-47.68%
Current year-42.61%
1 week 135
Extreme 135
175
1 month 115.1
Extreme 115.1
181.3
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
4,289
5 years 115.1
Extreme 115.1
10,430
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap.
01/04/26 Other

Executive/Senior Manager

20,000 0.2294%
18/03/26 Other

Chief Technology Officer

57,750 0.6624%
18/03/26 Other

Executive/Senior Manager

40,000 0.4588%
Change 5-day change 1-year change 3-year change Capi.($)
+3.85%+19.87%-59.33%-95.83% 5.73M
-1.29%-3.11%-0.39%+4.92% 49.7B
+2.48%-2.53%+366.48%+584.55% 38.09B
-1.40%+4.67%+7.68%+57.98% 35.29B
-1.64%-0.24%+27.02%-6.33% 35.13B
+0.06%+1.56%+4.41%+27.42% 27.22B
+2.87%-1.89% - - 16.14B
-0.72%-0.67%+67.51%+116.14% 15.36B
+1.12%+1.91%+15.90%+19.65% 13.89B
-0.25%+0.68%+14.96%-31.09% 13.02B
Average +0.49%+0.83%+49.36%+75.27% 24.38B
Weighted average by Cap. -0.15%-0.64%+73.49%+117.40%

Financials

2026 *2027 *
Net sales 1.48M 0 1.3M 1.2M 1.1M 2.08M 143M 2.12M 14.31M 5.62M 69.83M 5.57M 5.45M 241M 2.6M 0 2.27M 2.1M 1.93M 3.65M 251M 3.71M 25.07M 9.85M 122M 9.76M 9.55M 422M
Net income -16.69M -0 -14.59M -13.49M -12.38M -23.43M -1.61B -23.83M -161M -63.2M -785M -62.67M -61.29M -2.71B -13.92M -0 -12.16M -11.25M -10.32M -19.54M -1.34B -19.87M -134M -52.7M -655M -52.26M -51.11M -2.26B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
17/07/26 ILA 172.50 +3.85% 42,828
16/07/26 ILA 166.10 +13.92% 130,248
15/07/26 ILA 145.80 +5.65% 144,206
14/07/26 ILA 138.00 -11.25% 151,486
13/07/26 ILA 155.50 +8.06% 53,622

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock